After the death of a study participant, Iovance Biotherapeutics has announced a clinical hold on their trial evaluating LN-145, an experimental non-small cell l

Related Keywords

Friedrich Graf Finckenstein , Iovance Biotherapeutics , , Graf Finckenstein , Fda , Clinical Hold , N 145 , Non Small Cell Lung Cancer , Metastatic Disease , Chemotherapy , D , Ov Lun 202 ,